Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variant
Open Access
- 1 December 1998
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 103 (4) , 1045-1050
- https://doi.org/10.1046/j.1365-2141.1998.01112.x
Abstract
A recently discovered variant in the prothrombin gene (20210A) has been found in approximately 5–10% of patients with venous thromboembolism. It has been shown that patients with this variant present with high levels of prothrombin in plasma and this is maintained to be the most likely mechanism by which the risk of thrombosis is increased. We have evaluated prothrombin antigen levels in 50 carriers of the 20210A allele and compared with non‐carriers. 327 subjects were subdivided according to deficiency status and previous thrombosis. 30 symptomatic and 20 asymptomatic carriers had increased mean prothrombin levels as compared to symptomatic (n = 178) or asymptomatic (n = 99) non‐carriers. The percentage of subjects with prothrombin levels above cut‐off values of 1.15 u/ml or 1.30 u/ml was significantly higher in carriers of the prothrombin variant as compared to non‐carriers, regardless of a previous thrombosis. However, among non‐carriers the percentage of those with prothrombin levels above cut‐off values was significantly higher in the group of symptomatic as compared to asymptomatic individuals. In conclusion, increased prothrombin antigen levels, as detected by a specific ELISA, were found among 50 symptomatic and asymptomatic carriers of the 20210A prothrombin variant as well as among a large group of symptomatic non‐carriers. The data are in agreement with those found by using functional tests for the determination of prothrombin levels in these patients.Keywords
This publication has 23 references indexed in Scilit:
- Superior Sagittal Sinus Thrombosis in a Patient Heterozygous for the Novel 20210 A Allele of the Prothrombin GeneThrombosis and Haemostasis, 1998
- Budd-Chiari Syndrome in a Patient Heterozygous for the G20210A Mutation of the Prothrombin GeneThrombosis and Haemostasis, 1998
- Geographic Distribution of the 20210 G to A Prothrombin VariantThrombosis and Haemostasis, 1998
- The Heterozygous 20210 G/A Prothrombin Genotype Is Associated With Early Venous Thrombosis in Inherited Thrombophilias and Is Not Increased in Frequency in Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- A Prothrombin Gene Mutation Is Significantly Associated With Venous ThrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′‐untranslated region of the prothrombin geneBritish Journal of Haematology, 1997
- The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic population.British Journal of Haematology, 1997
- The 20210 A Allele of the Prothrombin Gene Is a Common Risk Factor among Swedish Outpatients with Verified Deep Venous ThrombosisThrombosis and Haemostasis, 1997
- Co-inheritance of the 20210A Allele of the Prothrombin Gene Increases the Risk of Thrombosis in Subjects with Familial ThrombophiliaThrombosis and Haemostasis, 1997
- Prevalence of the Prothrombin Gene Variant (nt20210A) in Venous Thrombosis and Arterial DiseaseThrombosis and Haemostasis, 1997